DNA-binding protein RFX5, Regulatory factor X 5, RFX5
Product description
A lack of MHC-II expression results in a severe
immunodeficiency syndrome called MHC-II deficiency, or the bare
lymphocyte syndrome (BLS; MIM 209920). At least 4 complementation
groups have been identified in B-cell lines established from
patients with BLS. The molecular defects in complementation groups
B, C, and D all lead to a deficiency in RFX, a nuclear protein
complex that binds to the X box of MHC-II promoters. The lack of
RFX binding activity in complementation group C results from
mutations in the RFX5 gene encoding the 75-kD subunit of RFX
(Steimle et al., 1995). RFX5 is the fifth member of the growing
family of DNA-binding proteins sharing a novel and highly
characteristic DNA-binding domain called the RFX motif. Multiple
alternatively spliced transcript variants have been found but the
full-length natures of only two have been determined. [provided by
RefSeq].1) Laird, K.M., et al. J. Mol. Biol. 403(1):40-51(2010)
Immunogen
This RFX5 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 237-266 amino acids from the Central region of human RFX5.
Western blot analysis in 293 cell line lysates (35ug/lane).
Application Notes
For WB starting dilution is: 1:1000:
Additional Information
Form
Liquid
Storage Instructions
Store at 4˚C for three months and -20˚C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.